|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Maryland Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MarylandLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Sequella, Inc.
| | | Phone: | (301) 762-7776 | Fax: | (301) 762-7778 | Year Established: | 1997 | Main Contact: | Mark Rampy, Ph.D., MBA, CBO | | Other Contacts: | David Mc Neeley, M.D., M.P.H.T.M,, Senior VP, Global Medical Programs Lisa Beth Ferstenberg, M.D., Medical Director Leo Einck, Ph.D., Co-Founder & CSO Carol A. Nacy, Ph.D., Co-Founder & CEO
| | Company Description | Sequella is a clinical stage biopharmaceutical company focused on commercializing improved treatments for diseases of epidemic potential. The company leverages its global influence, R&D platforms and infectious disease expertise to proactively address emerging health threats. Through focused execution, clear commercialization pathways, and strategic partnerships, Sequella intends to commercialize a broad product portfolio designed to treat global health threats with significant market opportunity. | |
|
|
|
|
|